EBOS Group (EBO.NZ) Akcie Kurz
EBOS Group Kurz
Za posledních 19 let vzrostly tržby EBOS Group o 21,7 % ročně a dosáhly 10,46 Mld. AUD. Zisk na akcii rostl o 8,9 % ročně za posledních 19 let. U EBOS Group je čistá marže 1,7 % převážně stabilní oproti 1,9 % před několika lety. Při dnešní ceně vychází dividendový výnos zhruba na 7,65 %. Výplatní poměr je kolem 112 % zisku. Dividenda rostla o 7,8 % ročně za posledních 19 let. Konsenzuální 12měsíční cílová cena pro EBOS Group je 31,15 AUD, asi nad cenu o 76,1 %. Z 13 analytiků jich 10 doporučuje nákup — celkový konsenzus je Koupit.
Cena akcie EBOS Group
Tato data přes Eulerpool API
100 000 požadavků/měs. zdarma · bez karty
Obchodní model EBOS Group a analýza akcií
Nejčastější otázky týkající se akcie EBOS Group
The business model of EBOS Group Ltd revolves around its position as a leading distributor of healthcare, laboratory, and pharmaceutical products. EBOS Group Ltd operates through two segments: Healthcare and Animal Care. The Healthcare segment supplies a broad range of medical products to public and private hospitals, pharmacies, and healthcare providers. The Animal Care segment focuses on providing veterinary products and services to veterinarians, farmers, and other animal healthcare professionals. With its robust distribution network and comprehensive product portfolio, EBOS Group Ltd strives to enhance healthcare outcomes and deliver value to its customers in the healthcare and animal care sectors.
EBOS Group Ltd is primarily active in the healthcare and pharmaceutical industries.
The main competitors of EBOS Group Ltd in the market include companies such as Sigma Healthcare Ltd, Australian Pharmaceutical Industries Limited (API), and New Zealand Pharmaceuticals Limited.
EBOS Group Ltd is a leading healthcare and animal care company based in New Zealand and Australia. With a rich history dating back to 1922, EBOS has grown to become a highly reputable player in the industry. Originally established as a pharmaceutical wholesaler, the company expanded its focus to healthcare and animal care through strategic acquisitions and partnerships. Today, EBOS Group Ltd operates across numerous sectors, including medical, dental, hospital, and retail pharmacy, as well as animal care and pet supplies. The company's commitment to delivering innovative solutions, along with its extensive network of partners and customer-centric approach, has contributed to its continued success and growth.
EBOS Group Ltd, a leading provider of healthcare and animal care products, has achieved several significant milestones. Firstly, the company expanded its operations internationally, establishing a strong presence in Australia and New Zealand. Secondly, EBOS made strategic acquisitions, including those of Symbion and Terry White Group, which further strengthened its market position. Additionally, EBOS achieved consistent revenue growth year on year, demonstrating its ability to deliver value to shareholders. Moreover, the company was recognized for its excellence through numerous awards, such as the Deloitte Top 200 Company of the Year. Overall, EBOS Group Ltd has successfully grown its business, expanded its reach, and gained industry recognition, solidifying its position in the market.
EBOS Group Ltd is primarily present in Australia and New Zealand.
EBOS Group Ltd represents values of integrity, collaboration, and excellence in its corporate philosophy. As a leading Australasian distributor of healthcare, medical, and pharmaceutical products, EBOS Group is committed to delivering high-quality solutions and services to its customers. The company's strong emphasis on ethical business practices and customer satisfaction has positioned it as a trusted partner in the healthcare industry. With a focus on continuous improvement and innovation, EBOS Group strives to enhance the well-being of individuals and communities through its diverse range of products and services.
Analytici aktuálně stanovují průměrnou cílovou cenu 29,62 AUD pro akcii EBOS Group (medián: 31,15 AUD), tedy +67,4 % vůči poslední ceně. Konsensus vychází z 13 hodnocení analytiků.
13 analytiků aktuálně hodnotí akcii EBOS Group: 11 doporučuje koupit, 1 držet a 1 prodat.
Při aktuálním kurzu se akcie EBOS Group obchoduje za 10,76 EUR (17,69 AUD).
Akcie EBOS Group (EBO.NZ) je kótována na 3 burzách, mimo jiné: ASX (EBO.AX), Frankfurt (EJG.F).
The EBOS Group Limited is a leading distributor of medical and pharmaceutical products in Australia, New Zealand, and Asia. Their business model is based on supplying products to medical facilities, pharmacies, and healthcare providers. The company operates in various sectors, including Healthcare, Animal Care, and Scientific. In the Healthcare sector, the EBOS Group is an important supplier of medical devices and consumables. They offer a wide range of products, ranging from surgical instruments and diagnostic devices to incontinence products and bandages. In the Animal Care sector, EBOS holds an extensive product list of veterinary medicines and supplies. The EBOS Group is one of the largest suppliers of animal medicines in Australia and New Zealand. The company works closely with veterinarians and professionals in animal health to ensure the best possible fulfillment of the needs of pets and livestock. In the Scientific sector, EBOS trades in laboratory equipment, chemicals, and other scientific products. The company also provides services such as calibration, repair, and maintenance of laboratory equipment. The EBOS Group aims to provide its customers with the highest quality and most innovative products and services. The company holds a wide range of products and brands in stock, including its own brands and established brands such as Johnson & Johnson and Roche. The business model of the EBOS Group is based on providing products and services that meet the needs of its customers. The company has established a network of distribution centers throughout Australia, New Zealand, and Asia to ensure that its customers are supplied quickly and effectively. The EBOS Group also has a strong online presence to enable its customers to easily purchase and access their products. The company also utilizes advanced IT systems and technologies to optimize the ordering and delivery process and ensure fast and reliable product delivery. Overall, the business model of the EBOS Group offers a wide range of high-quality products and services for diverse customer needs. The company is well positioned to leverage growth in the Healthcare, Animal Care, and Scientific sectors in Australia, New Zealand, and Asia, and strengthen its position as a leading company in the medical and pharmaceutical industry. Answer: The EBOS Group Limited is a leading distributor of medical and pharmaceutical products in Australia, New Zealand, and Asia. They provide products to medical facilities, pharmacies, and healthcare providers, and operate in the Healthcare, Animal Care, and Scientific sectors. They offer a wide range of products and brands, have a strong online presence, and utilize advanced technology to optimize the ordering and delivery process. The EBOS Group aims to provide high-quality products and services and is well positioned for growth in the industry.
Tržby za EBOS Group činí 10,46 Mld. AUD. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.
Zisk za EBOS Group činí 174,68 Mil. AUD. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.
Poměr ceny k zisku (P/E) EBOS Group je aktuálně 21,02. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie EBOS Group.
Poměr ceny k tržbám (P/S) EBOS Group je aktuálně 0,35. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie EBOS Group.
Score kvality pro EBOS Group je 3/10.
ISIN EBOS Group je NZEBOE0001S6. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.
WKN EBOS Group je 724635. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.
Ticker EBOS Group je EBO.NZ. Symbol tickeru se používá k obchodování akcií EBOS Group na burze.
EBOS Group akcie
Všechny fundamentální údaje o EBOS Group v podrobné analýze
Naše analýzy akcií společnosti EBOS Group zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti EBOS Group. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: